FDA Approved: PAZOPANIB — Original Application (Torrent Pharmaceuticals Limited)

View source ↗

Summary

FDA approves Torrent Pharmaceuticals Limited's pazopanib hydrochloride as an original generic application (ANDA 219922).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma
• Soft Tissue Sarcoma

Drugs mentioned

• Pazopanib (Pazopanib)

Snippet

ORIG AP for PAZOPANIB (PAZOPANIB HYDROCHLORIDE)